Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Froehner

Showing results (61-70 of 191) with videos related to

Pageof 20
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
Comorbidity and mortality after brachytherapy: in regard to Nanda et alMichael Froehner, Rainer Koch, Manfred P Wirth
European Urology|July 7, 2015
Re: Syed Johar Raza, Timothy Wilson, James O. Peabody, et al. Long-term Oncologic Outcomes Following Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. Eur Urol 2015;68:721-8Michael Froehner, Rainer Koch, Manfred P Wirth
Urology|January 26, 2005
Renal staghorn calculus?Michael Froehner, Peter Aikele, Manfred P Wirth
European Urology|October 13, 2015
Re: Jesse D. Sammon, Firas Abdollah, Anthony D'Amico, et al. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol 2015;68:756-65Michael Froehner, Rainer Koch, Manfred P Wirth
Cancer|September 12, 2014
Charlson score and competing mortalityMichael Froehner, Rainer Koch, Manfred P Wirth
European Urology|September 30, 2006
Antiandrogens in the treatment of prostate cancerManfred P Wirth, Oliver W Hakenberg, Michael Froehner
World Journal of Urology|March 3, 2007
Optimal treatment of locally advanced prostate cancerManfred P Wirth, Oliver W Hakenberg, Michael Froehner
Urologia Internationalis|July 14, 2007
Molecular therapy in urologic oncologyMichael Froehner, Oliver W Hakenberg, Manfred P Wirth
Urologic Oncology|September 12, 2006
11C-acetate positron emission tomography for occult prostate cancerMichael Froehner, Bettina Beuthien-Baumann, Manfred P Wirth
Annals of Surgical Oncology|November 30, 2017
Age and Charlson ScoreMichael Froehner, Rainer Koch, Bs Manfred P Wirth
Pageof 20

Showing results (61-70 of 191) with videos related to

Sort By:
Pageof 20
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
Comorbidity and mortality after brachytherapy: in regard to Nanda et alMichael Froehner, Rainer Koch, Manfred P Wirth
European Urology|July 7, 2015
Re: Syed Johar Raza, Timothy Wilson, James O. Peabody, et al. Long-term Oncologic Outcomes Following Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. Eur Urol 2015;68:721-8Michael Froehner, Rainer Koch, Manfred P Wirth
Urology|January 26, 2005
Renal staghorn calculus?Michael Froehner, Peter Aikele, Manfred P Wirth
European Urology|October 13, 2015
Re: Jesse D. Sammon, Firas Abdollah, Anthony D'Amico, et al. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol 2015;68:756-65Michael Froehner, Rainer Koch, Manfred P Wirth
Cancer|September 12, 2014
Charlson score and competing mortalityMichael Froehner, Rainer Koch, Manfred P Wirth
European Urology|September 30, 2006
Antiandrogens in the treatment of prostate cancerManfred P Wirth, Oliver W Hakenberg, Michael Froehner
World Journal of Urology|March 3, 2007
Optimal treatment of locally advanced prostate cancerManfred P Wirth, Oliver W Hakenberg, Michael Froehner
Urologia Internationalis|July 14, 2007
Molecular therapy in urologic oncologyMichael Froehner, Oliver W Hakenberg, Manfred P Wirth
Urologic Oncology|September 12, 2006
11C-acetate positron emission tomography for occult prostate cancerMichael Froehner, Bettina Beuthien-Baumann, Manfred P Wirth
Annals of Surgical Oncology|November 30, 2017
Age and Charlson ScoreMichael Froehner, Rainer Koch, Bs Manfred P Wirth
Pageof 20